La Jolla Institute for Immunology (LJI), one of the leading research organizations dedicated to studying the immune system announced today that it has signed a licensing agreement with Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, and conjugates...
Increased pollen concentrations correlate with higher SARS-CoV-2 infection rates. When airborne pollen levels are higher, increased SARS-CoV-2 infection rates can be observed. These results were determined by a large-scale study conducted by an international team headed by researchers at the Technical University of Munich (TUM) and the Helmholtz Zentrum München...
Jubilant Biosys and Yale University have announced a research collaboration for multiple small molecule research programs. Under the scope of this partnership, Jubilant Biosys will provide research services to investigators at Yale University working on novel therapeutic targets. Areas of collaboration include medicinal chemistry, structural biology, in-vitro and in-vivo pharmacology among others....
LifeArc and the Medical Research Council (MRC), with support from the Biotechnology and Biological Sciences Research Council (BBSRC), today announce three major investments totalling £18m to create a national network of cutting-edge “Gene Therapy Innovation Hubs”. The £18m funding will support the creation of three dedicated facilities to advance the clinical development of new genetic treatments...
Abbott has announced the formation of the Abbott Pandemic Defence Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats. By connecting global centres of excellence in laboratory testing, genetic sequencing and public health research, the program will identify new pathogens, analyse potential risk level, rapidly develop and deploy new diagnostic testing and assess public health impact in real time...
CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), otherwise known as organ-on-a-chip, has announced it has received a grant from Innovate UK, the UK’s innovation agency, to develop human-relevant MPS to advance investigations into SARS-CoV-2 infection. The funding will be used to develop and test advanced cell culture models that represent different regions of the lung ...
INTEGRA Biosciences’ VOYAGER adjustable tip spacing pipette is routinely used to combat the challenges associated with repetitive pipetting tasks in molecular biology. These workflows often consist of lengthy, multistep protocols. Ahuva Odenheimer, a senior research associate working on behalf of venture capital firm Flagship Pioneering, explained how the VOYAGER increases...
Avacta Group plc, the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, announces that the AffiDX® SARS-CoV-2 rapid antigen lateral flow test detects the dominant new variants of the coronavirus, known as the B117, or ‘Kent’, variant, and the D614G variant, as well as the original strain....
CDI Labs – a biotechnology company based in Puerto Rico – is using INTEGRA’s VIAFLO and VOYAGER electronic pipettes to streamline workflows and improve accuracy for the development of next generation proteomics products. The company is well-known for its flagship product – the HuProt™ Human Proteome Microarray – and has since expanded its portfolio to include a catalogue of over 2,000 monoclonal antibodies designed to accelerate research and advance discoveries that improve human health....
Colorado Extraction Systems has manufactured user-friendly extraction systems to meet your needs and deliver the product on time. With their innovative technology and extraction systems made easy, specific business needs are met seamlessly. Ethanol Extractions is a process used in fine liquor distillation. Professional labs perform ethanol extraction in large volumes by using spirit distillation, steam distillation, and solvent recovery process....
A new UK study will seek to understand the immune response to COVID-19 vaccinations in patients with certain immunosuppressed conditions, including cancer. The OCTAVE trial, which is funded by the Medical Research Council (MRC), is a collaborative research project involving groups in the Universities of Glasgow, Birmingham, Oxford, Liverpool, Imperial College London and Leeds Teaching Hospitals NHS Trust....
Capitainer has announced that Sweden’s Västerbotten Region will be the first region to use Capitainer's home sampling kit, qDBS, for antibody testing for COVID-19. Adults will be able to order the kit online via the national online health portal 1177 in collaboration with Direkttest.se. People over the age of 16 in Västerbotten Region will be able to test for antibodies against COVID-19 at home...
An international consortium, led by scientists in Scotland, have devised a Coronavirus Toolkit which gives researchers from across the world open access to materials, including antibodies and genetic tools, which can be easily and immediately ordered via an online portal – to further research into COVID-19. The toolkit was designed and validated by scientists at the MRC-University of Glasgow Centre for Virus Research...
Veolia Water Technologies UK’s (VWT UK) innovative PURELAB® Quest unit has been selected to provide a complete purified water solution for a newly refurbished laboratory at University College London (UCL). The compact unit, which delivers all required types of purified water, was chosen to help maximise the available workspace. Located on the main UCL campus, the Anatomy Building has been undergoing phased updates to much of its interior, including several separate lab areas...
Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, announces that it has received the first data for its SARS-CoV-2 rapid antigen test from ongoing clinical studies in Europe and the UK. These data show excellent performance of the test in identifying patients with an infectious viral load and no false positive results. Avacta’s SARS-CoV-2 rapid antigen test has been developed to identify infectious individuals so that they can isolate promptly and reduce the spread of COVID-19....
Linkam Scientific’s PE120 Peltier system formed part of the experimental set-up used to develop a radical new diagnostic test for the SARS CoV-2 virus at Ohio State University (OSU), Columbus, Ohio, USA. The global outbreak of COVID-19 has prompted scientists to focus their research on rapid and robust diagnostic tests. Reverse-transcription polymerase chain reaction (RT-PCR) assays – the ‘gold-standard’ for molecular clinical diagnostics – became available quickly, however this provides relatively long characterisation times...
INTEGRA Biosciences’ EVOLVE manual pipettes and VOYAGER electronic adjustable tip spacing pipettes are both integral parts of the lab workflows at the University of California, Riverside (UCR), where researchers are investigating the evolution and ecology of a fascinating group of fish that includes a popular aquatic pet, the guppy. Samantha Levell, a PhD candidate at UCR, explained...
Smiths Detection, a global leader in threat detection and security screening technologies, reports that its BioFlash® Biological Identifier is capable of detecting SARS-CoV-2 in the air following tests conducted by the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). The tests were performed using live SARS-CoV-2 virus in a Biosafety Level 3 containment area at Fort Detrick, Maryland...
Academics at Northumbria University, Newcastle, have been backed by the Government’s Defence and Security Accelerator (DASA) to develop an antiviral coating suitable for use on everyday surfaces. DASA, part of the Ministry of Defence, has commissioned a research team from Northumbria to develop a new type of multifunctional antiviral coating which could form part of the country’s biodefence - crucial to combatting public health crises such as the ongoing COVID-19 pandemic....
FairJourney Biologics (FJB) and IONTAS, leaders in the discovery and optimization of antibodies, have announced the launch of a new protein sciences division, Flow Eighteen38. The new business unit has been introduced to accelerate customer antibody research projects, by delivering reagents, purified proteins, and characterization data on antibody panels and leads....
Labs are increasingly choosing INTEGRA Biosciences’ liquid handling instruments to help them address growing workloads associated with Human papilloma virus (HPV) screening. Several studies have recently suggested that PCR-based screening is more accurate and offers earlier detection of pre-cancerous growths than the conventional Papanicolaou (Pap) test and liquid-based cytology, leading to a gradual shift towards molecular diagnostics approaches....
Illumina, Inc. has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator in the U.S. and UK. The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups, invested in four companies for the second funding cycle of Illumina Accelerator Cambridge, UK and five companies for the twelfth funding cycle of Illumina Accelerator San Francisco Bay Area....
La Jolla Institute for Immunology (LJI), one of the leading research organizations dedicated to studying the immune system announced today that it has signed a licensing agreement with Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, and conjugates...
Increased pollen concentrations correlate with higher SARS-CoV-2 infection rates. When airborne pollen levels are higher, increased SARS-CoV-2 infection rates can be observed. These results were determined by a large-scale study conducted by an international team headed by researchers at the Technical University of Munich (TUM) and the Helmholtz Zentrum München...
Jubilant Biosys and Yale University have announced a research collaboration for multiple small molecule research programs. Under the scope of this partnership, Jubilant Biosys will provide research services to investigators at Yale University working on novel therapeutic targets. Areas of collaboration include medicinal chemistry, structural biology, in-vitro and in-vivo pharmacology among others....
LifeArc and the Medical Research Council (MRC), with support from the Biotechnology and Biological Sciences Research Council (BBSRC), today announce three major investments totalling £18m to create a national network of cutting-edge “Gene Therapy Innovation Hubs”. The £18m funding will support the creation of three dedicated facilities to advance the clinical development of new genetic treatments...
Abbott has announced the formation of the Abbott Pandemic Defence Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats. By connecting global centres of excellence in laboratory testing, genetic sequencing and public health research, the program will identify new pathogens, analyse potential risk level, rapidly develop and deploy new diagnostic testing and assess public health impact in real time...
CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), otherwise known as organ-on-a-chip, has announced it has received a grant from Innovate UK, the UK’s innovation agency, to develop human-relevant MPS to advance investigations into SARS-CoV-2 infection. The funding will be used to develop and test advanced cell culture models that represent different regions of the lung ...
INTEGRA Biosciences’ VOYAGER adjustable tip spacing pipette is routinely used to combat the challenges associated with repetitive pipetting tasks in molecular biology. These workflows often consist of lengthy, multistep protocols. Ahuva Odenheimer, a senior research associate working on behalf of venture capital firm Flagship Pioneering, explained how the VOYAGER increases...
Avacta Group plc, the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, announces that the AffiDX® SARS-CoV-2 rapid antigen lateral flow test detects the dominant new variants of the coronavirus, known as the B117, or ‘Kent’, variant, and the D614G variant, as well as the original strain....
CDI Labs – a biotechnology company based in Puerto Rico – is using INTEGRA’s VIAFLO and VOYAGER electronic pipettes to streamline workflows and improve accuracy for the development of next generation proteomics products. The company is well-known for its flagship product – the HuProt™ Human Proteome Microarray – and has since expanded its portfolio to include a catalogue of over 2,000 monoclonal antibodies designed to accelerate research and advance discoveries that improve human health....
Colorado Extraction Systems has manufactured user-friendly extraction systems to meet your needs and deliver the product on time. With their innovative technology and extraction systems made easy, specific business needs are met seamlessly. Ethanol Extractions is a process used in fine liquor distillation. Professional labs perform ethanol extraction in large volumes by using spirit distillation, steam distillation, and solvent recovery process....
A new UK study will seek to understand the immune response to COVID-19 vaccinations in patients with certain immunosuppressed conditions, including cancer. The OCTAVE trial, which is funded by the Medical Research Council (MRC), is a collaborative research project involving groups in the Universities of Glasgow, Birmingham, Oxford, Liverpool, Imperial College London and Leeds Teaching Hospitals NHS Trust....
Capitainer has announced that Sweden’s Västerbotten Region will be the first region to use Capitainer's home sampling kit, qDBS, for antibody testing for COVID-19. Adults will be able to order the kit online via the national online health portal 1177 in collaboration with Direkttest.se. People over the age of 16 in Västerbotten Region will be able to test for antibodies against COVID-19 at home...
An international consortium, led by scientists in Scotland, have devised a Coronavirus Toolkit which gives researchers from across the world open access to materials, including antibodies and genetic tools, which can be easily and immediately ordered via an online portal – to further research into COVID-19. The toolkit was designed and validated by scientists at the MRC-University of Glasgow Centre for Virus Research...
Veolia Water Technologies UK’s (VWT UK) innovative PURELAB® Quest unit has been selected to provide a complete purified water solution for a newly refurbished laboratory at University College London (UCL). The compact unit, which delivers all required types of purified water, was chosen to help maximise the available workspace. Located on the main UCL campus, the Anatomy Building has been undergoing phased updates to much of its interior, including several separate lab areas...
Linkam Scientific’s PE120 Peltier system formed part of the experimental set-up used to develop a radical new diagnostic test for the SARS CoV-2 virus at Ohio State University (OSU), Columbus, Ohio, USA. The global outbreak of COVID-19 has prompted scientists to focus their research on rapid and robust diagnostic tests. Reverse-transcription polymerase chain reaction (RT-PCR) assays – the ‘gold-standard’ for molecular clinical diagnostics – became available quickly, however this provides relatively long characterisation times...
INTEGRA Biosciences’ EVOLVE manual pipettes and VOYAGER electronic adjustable tip spacing pipettes are both integral parts of the lab workflows at the University of California, Riverside (UCR), where researchers are investigating the evolution and ecology of a fascinating group of fish that includes a popular aquatic pet, the guppy. Samantha Levell, a PhD candidate at UCR, explained...
Smiths Detection, a global leader in threat detection and security screening technologies, reports that its BioFlash® Biological Identifier is capable of detecting SARS-CoV-2 in the air following tests conducted by the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). The tests were performed using live SARS-CoV-2 virus in a Biosafety Level 3 containment area at Fort Detrick, Maryland...
Academics at Northumbria University, Newcastle, have been backed by the Government’s Defence and Security Accelerator (DASA) to develop an antiviral coating suitable for use on everyday surfaces. DASA, part of the Ministry of Defence, has commissioned a research team from Northumbria to develop a new type of multifunctional antiviral coating which could form part of the country’s biodefence - crucial to combatting public health crises such as the ongoing COVID-19 pandemic....
FairJourney Biologics (FJB) and IONTAS, leaders in the discovery and optimization of antibodies, have announced the launch of a new protein sciences division, Flow Eighteen38. The new business unit has been introduced to accelerate customer antibody research projects, by delivering reagents, purified proteins, and characterization data on antibody panels and leads....
Labs are increasingly choosing INTEGRA Biosciences’ liquid handling instruments to help them address growing workloads associated with Human papilloma virus (HPV) screening. Several studies have recently suggested that PCR-based screening is more accurate and offers earlier detection of pre-cancerous growths than the conventional Papanicolaou (Pap) test and liquid-based cytology, leading to a gradual shift towards molecular diagnostics approaches....
Illumina, Inc. has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator in the U.S. and UK. The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups, invested in four companies for the second funding cycle of Illumina Accelerator Cambridge, UK and five companies for the twelfth funding cycle of Illumina Accelerator San Francisco Bay Area....